|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-7-4
|
|
pubmed:abstractText |
Human mesenchymal stem cells (hMSCs) are pluripotent cells that can differentiate to various mesenchymal cell types. Recently, a method to isolate hMSCs from bone marrow and expand them in culture was described. Here we report on the use of hMSCs as a platform for gene therapy aimed at bone lesions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1099-498X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
240-51
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11437329-Adenoviridae,
pubmed-meshheading:11437329-Animals,
pubmed-meshheading:11437329-Bone Development,
pubmed-meshheading:11437329-Bone Diseases,
pubmed-meshheading:11437329-Bone Marrow Cells,
pubmed-meshheading:11437329-Bone Morphogenetic Protein 2,
pubmed-meshheading:11437329-Bone Morphogenetic Proteins,
pubmed-meshheading:11437329-Bone Regeneration,
pubmed-meshheading:11437329-Cells, Cultured,
pubmed-meshheading:11437329-Gene Therapy,
pubmed-meshheading:11437329-Genetic Vectors,
pubmed-meshheading:11437329-Humans,
pubmed-meshheading:11437329-Mesoderm,
pubmed-meshheading:11437329-Mice,
pubmed-meshheading:11437329-Recombinant Proteins,
pubmed-meshheading:11437329-Stem Cells,
pubmed-meshheading:11437329-Transduction, Genetic,
pubmed-meshheading:11437329-Transforming Growth Factor beta
|
|
pubmed:articleTitle |
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy.
|
|
pubmed:affiliation |
Hebrew University-Hadassah Medical and Gene Therapy Center, Jerusalem, Israel.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
